To investigate whether treatment with PFC-FD is effective in patients with impaired ovarian function.

Study on the usefulness of PFC-FD in cases of decreased ovarian function - Study on the usefulness of PFC-FD

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000043811

Enrollment

100

Registered

2021-04-05

Start date

2021-04-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Decreased ovarioan reserve, Premature ovarian failure

Interventions

Intra-ovarian injection of PFC-FD

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Decresed ovarian reserve:according to Bologna criteria. Premature Ovarian insaficiency:age<40 years,amenorrhea for at least four months, and elevated FSH levels >25IU/L recorded on two occasions >4 weeks apart.

Exclusion criteria

Exclusion criteria: autoimmune disorders, sexually transmitted diseases, infectious diseases, tubal factor infertility/tubal obstruction, chronic inflammatory diseases, endometriosis, chronic endometritis, and endocrine disorders such as thyroid dysfunction,were excluded in general. Body Mass Index (BMI) above 30 or less than 18.5, hypothalamic-pituitary disorders

Design outcomes

Primary

Measure	Time frame
pregnancy rate	—

Secondary

Measure	Time frame
Number of eggs retrieved, good embryo rate, blood hormone level, blood AMH level	—

Countries

Japan

Contacts

Public ContactDaisuke Kadogami

IVF Namba Clinic Doctor

kadogami515@ivfjapan.com0665348824

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026